Advertisement

Gardner Syndrome

  • Alexandra Golant
  • Joshua A. Zeichner
Chapter

Abstract

Gardner syndrome (GS) is a phenotypic variant of familial adenomatous polyposis (FAP). The syndrome is characterized by premalignant intestinal polyposis and distinct extraintestinal features, such as multiple epidermoid cysts, osteomas, and desmoid or fibrous tumors of the skin and soft tissue [1].

Keywords

Papillary Thyroid Carcinoma Familial Adenomatous Polyposis Adenomatous Polyposis Coli Desmoid Tumor Epidermoid Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Juhn E, Khachemoune A. Gardner syndrome: skin manifestations, differential diagnosis and management. Am J Clin Dermatol. 2010;11(2):117–22.PubMedCrossRefGoogle Scholar
  2. 2.
    Ponti G, Pellacani G, Seidenari S, Pollio A, Muscatello U, Tomasi A. Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol. 2012;85(3):239–56.PubMedCrossRefGoogle Scholar
  3. 3.
    Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol. 2007;61(2):153–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Wallis YL, Morton DG, McKeown CM, Macdonald F. Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet. 1999; 36(1): 14–20.PubMedGoogle Scholar
  5. 5.
    Doxey BW, Kuwada SK, Burt RW. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. 2005;3(7):633–64.PubMedCrossRefGoogle Scholar
  6. 6.
    Kanitakis J. Adnexal tumours of the skin as markers of cancer-prone syndromes. J Eur Acad Dermatol Venereol. 2010;24(4):379–87.PubMedCrossRefGoogle Scholar
  7. 7.
    Bussey HJR. Familial polyposis coli: Family studies, histopathology, differential diagnosis, and results of treatment. Baltimore: Johns Hopkins University Press; 1975Google Scholar
  8. 8.
    Järvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut. 1992;33(3):357–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Bülow S, Faurschou Nielsen T, Bülow C, Bisgaard ML, Karlsen L, Moesgaard F. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis. 1996;11(2):88–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Shen Z, Hoffman JD, Hao F, Pier E. More than just skin deep: faciocutaneous clues to genetic syndromes with malignancies. Oncologist. 2012;17(7):930–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Bayliss SJ, Berk DR, Burton BK, Cohen BA, Bree AF, Sybert VP. Other genodermatoses. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. St. Louis, MO: Mosby/Elsevier; 2012.Google Scholar
  12. 12.
    Leal RF, Silva PV, Ayrizono Mde L, Fagundes JJ, Amstalden EM, Coy CS. Desmoid tumor in patients with familial adenomatous polyposis. Arq Gastroenterol. 2010;47(4):373–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Shah KR, Boland CR, Patel M, Thrash B, Menter A. Cutaneous manifestations of gastrointestinal disease: part I. J Am Acad Dermatol. 2013;68(2):189.e1–189.e21.CrossRefGoogle Scholar
  14. 14.
    Shields JA, Shields CL, Shah PG, et al. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis and Gardner syndrome. Ophthalmology. 1992;99(11):1709–13.PubMedCrossRefGoogle Scholar
  15. 15.
    Baker RH, Heinemann MH, Miller HH, DeCosse JJ. Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis. Am J Med Genet. 1988;31(2): 427–35.PubMedCrossRefGoogle Scholar
  16. 16.
    Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A. 2006;140(3):200–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Tsao H. Update on familial cancer syndromes and the skin. J Am Acad Dermatol. 2000; 42(6):939–69.PubMedCrossRefGoogle Scholar
  18. 18.
    Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044–58.PubMedCrossRefGoogle Scholar
  19. 19.
    Pujol RM, Casanova JM, Egido R, Pujol J, de Moragas JM. Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome? Pediatr Dermatol. 1995;12(4):331–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Coffin CM, Hornick JL, Zhou H, Fletcher CD. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol. 2007; 31(3):410–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Naylor EW, Lebenthal E. Early detection of adenomatous polyposis coli in the Gardner’s syndrome. Pediatrics. 1979;63(2):222–7.PubMedGoogle Scholar
  22. 22.
    de Camargo VP, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 2010;116(9):2258–65.PubMedGoogle Scholar
  23. 23.
    Hughes-Fulford M, Boman B. Growth regulation of Gardner’s syndrome colorectal cancer cells by NSAIDs. Adv Exp Med Biol. 1997;407:433–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am. 2002;31(4):1107–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Gallagher MC, Phillips RK, Bulow S. Surveillance and management of upper gastrointestinal disease in familial adenomatous polyposis. Fam Cancer. 2006;5(3):263–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of DermatologyThe Mt. Sinai HospitalNew YorkUSA
  2. 2.Department of DermatologyMt. Sinai School of MedicineNew YorkUSA

Personalised recommendations